08/09/2013

New Vaccine Beats Malaria in Early Trials

6:52 minutes

Reporting in Science, researchers write of an intravenous vaccine that offered complete protection against malaria in a small clinical trial—but only after five doses. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, discusses steps needed to turn this early success into a practical vaccine.

Segment Guests

Anthony Fauci

Anthony Fauci is director of the National Institute of Allergy and Infectious Diseases at the The National Institutes of Health in Bethesda, Maryland.

Meet the Producer

About Christopher Intagliata

Christopher Intagliata is Science Friday’s senior producer. He once served as a prop in an optical illusion and speaks passable Ira Flatowese.